SEC Filings for China SXT Pharmaceuticals Inc. (SXTC)

$ 0.9376   0.0776 (+9.02%) Volume: 1.56m 3:59 PM EST Feb 21, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals1202/14/2020
SC 13GStatement of acquisition of beneficial ownership by individuals802/07/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19346901/31/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19343112/16/2019
424B8Prospectus [Rule 424(b)(8)]15611/05/2019
20-F/A[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]4108/19/2019
20-FRegistration statement / Annual report / Transition report12808/15/2019
NT 20-FNotification of inability to timely file Form 20-F307/31/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934307/31/2019
F-1/A[Amend] Registration statement for certain foreign private issuers67306/21/2019
F-1Registration statement for securities of certain foreign private issuers15805/30/2019
SC 13GStatement of acquisition of beneficial ownership by individuals905/08/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 193412305/03/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 193425104/17/2019
<<
First
<
Prev
1234